Clinical Trial Update: Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy [NA]

View source ↗

Summary

A clinical trial evaluating short-infusion ziv-aflibercept in combination chemotherapy for metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | NA | Status: WITHDRAWN